Table 1.
Clinical characteristics of the subjects included in the study
| Whole group (18) | Control (9) | GDM (9) | P | |
|---|---|---|---|---|
| Maternal age, years | 35.06 ± 5.34 | 34.11 ± 6.49 | 36.00 ± 4.06 | .470 |
| Parity ≥1, n (%) | 10 (55.6) | 4 (44.4) | 6 (66.7) | .603 |
| Prepregnancy BMI, kg/m2 | 26.42 ± 4.43 | 24.85 ± 3.31 | 28.00 ± 5.03 | .067 |
| Gestational weight gain, kg | 10.09 ± 5.10 | 11.83 ± 5.29 | 8.14 ± 4.37 | .081 |
| 1‐h 50‐g glucose challenge, mg/dL | 148.94 ± 37.35 | 120.44 ± 24.11 | 177.44 ± 23.57 | <.001 |
| Maternal glucose, mg/dL | 79.23 ± 12.69 | 77.57 ± 7.68 | 81.17 ± 17.53 | .632 |
| HbA1c % | ‐ | ‐ | 5.36 ± 0.25 | |
| Maternal HOMA‐IR | 2.75 ± 1.93 | 1.70 ± 3.98 | 3.98 ± 2.20 | .052 |
| Maternal insulin | 14.20 ± 8.31 | 10.13 ± 4.23 | 18.27 ± 9.59 | .061 |
| Maternal total cholesterol, mg/dL | 212.31 ± 38.21 | 224.71 ± 42.59 | 197.83 ± 29.35 | .220 |
| Maternal triglycerides, mg/dL | 224.38 ± 82.76 | 244.00 ± 87.93 | 201.50 ± 77.41 | .379 |
| Week at delivery, weeks | 38.17 ± 0.99 | 37.78 ± 0.83 | 38.56 ± 1.01 | .097 |
| Newborn weight, g | 3,396 ± 454 | 3,385 ± 448 | 3,408 ± 487 | .517 |
| Placental weight, g | 661.67 ± 130.45 | 625 ± 66 | 698 ± 170 | .460 |
| Suprailiac skinfold, mm | 3.35 ± 0.49 | 3.29 ± 0.39 | 3.42 ± 0.60 | .917 |
| Cord blood glucose, mg/dL | 68.06 ± 11.96 | 64.25 ± 12.07 | 71.87 ± 11.32 | .213 |
| Infant male sex, n (%) | 9 (50%) | 5 (55.6) | 4 (44.4) | .637 |
| Cord blood insulin | 6.70 ± 4.61 | 6.04 ± 3.53 | 7.35 ± 5.63 | .567 |
| Cord blood total cholesterol, mg/dL | 60.44 ± 8.97 | 56.00 ± 3.70 | 64.88 ± 10.66 | .054 |
| Cord blood triglycerides, mg/dL | 29.56 ± 18.30 | 23.75 ± 4.95 | 33.38 ± 24.82 | .215 |